The ‘East Asian Paradox’ refers to a unique risk-benefit trade-off observed in Asian patients for thrombosis versus bleeding, initially identified in those with coronary artery disease (CAD) ...
Peripandemic outcomes of infants treated for sentinel congenital heart diseases in England and Wales
Background Infants with congenital heart disease (CHD) are clinically vulnerable to cardiac deteriorations and intercurrent ...
While iterative developments have improved outcomes of patients with myocardial infarction, mortality in patients with acute ...
Background Percutaneous coronary intervention (PCI) is a well-established treatment for coronary artery disease, one of the most significant causes of morbidity and mortality worldwide. Intracoronary ...
Background Left ventricular (LV) mass is closely associated with atherosclerotic heart disease, but the mechanisms are not well defined. This study aimed to evaluate the risk factors associated with ...
Background Over the past three decades, significant disparities in the global burden of cardiovascular disease (CVD) have ...
Aims Clopidogrel is the most commonly prescribed thienopyridine as part of dual anti-platelet therapy for the treatment of ...
Background Training in complex high-risk indicated percutaneous coronary intervention (CHIP-PCI) has frequently been reserved for established operators (consultants ...
Introduction Advancements in technology and cardiovascular management with timely coronary revascularization have improved the survival rate of patients with myocardial infarction. Secondary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback